Background Image
Table of Contents Table of Contents
Previous Page  117 / 164 Next Page
Information
Show Menu
Previous Page 117 / 164 Next Page
Page Background

3

A.

A safety review must be performed for a method to be recognized as First Action.

1

2

ERP has addressed all safety concerns were addressed as part of the two year period. Appropriate

3

warnings, precautionary statements, and instructions are included in the method. Method users are

4

instructed to consult the MSDS prior to using chemicals and to adhere to the safety precautions

5

provided therein. Method users are also instructed to where personal protective equipment when

6

necessary.

7

8

B.

All safety concerns identified during the 2 year evaluation period must be addressed.

9

10

Discussions on method safety transpired during the meeting during which the method was adopted and

11

subsequently when the method was selected for the tract to Final Action recommendation. Please see

12

the Method Evaluation spreadshee

t 2

developed by the formula manufacturers to aid the ERP in down

13

selecting one method per nutrient.

14

15

C.

Guidance and support can be obtained from the AOAC Committee on Safety.

16

17

In addition to the expertise of ERP members’ familiarity with the safety issues around chemicals used in

18

this method, the AOAC Method Safety and Risk Assessment Guide

3

was provided and served as

19

reference for method authors and ERP members.

20

21

REFERENCE MATERIALS:

22

A.

Document efforts undertaken to locate reference materials. Method may still progress to Final

23

Action even if reference materials are not available.

24

25

During its second meeting in April 2011, SPIFAN approved the first of the five SMPRs in which NIST

26

Infant formula SRM 1849 and now SRM 1849a was the stated at the primary reference material. This

27

SRM is stated as the primary reference material in all SPIFAN SMPRs. The NIST SRM 1849a material was

28

tested in the reproducibility assessment for AOAC 2012.1

6 4

.

29

2

Method Evaluation Form for AOAC 2012.16, Pantothenic acid (Vitamin B5) in Infant Formula and Adult/Pediatric Nutritional

Formula UHPLC-MS/MS

3

AOAC Method Safety and Risk Assessment Document

4

Data report for assessing AOAC 2012.16 with NIST SRM 1849a